Skip to content
OpenCapital
Get started

SELLAS Life Sciences Group, Inc. SLS Deposits on Licenses

Other financials

Income statement

See full
Revenue-—
Gross profit-—
Operating income-$9.3M-52.6%
Net income-$8.4M-44.6%
EPS (diluted)-$0.05+28.6%

Balance sheet

See full
Cash & equivalents$107.1M+277%
Total debt$871.0K+0.1%
Total equity$107.4M+287%
Total assets$114.2M+227%

Cash flow

See full
Operating cash flow-$8.8M+2.5%

Valuation

See full
Market cap$1.8B+674%
Enterprise value$1.7B+826%

Profitability

See full
Gross margin90%-7.4pp
Operating margin-4,195%-4,591pp
Net margin-4,130.1%-4,444pp
FCF margin-300.5%—

Returns & leverage

See full
Return on equity-43.6%-17.9pp
Debt / equity0×0.0×
Current ratio17.2×+12.6×

Where this comes from

Reported directly by SELLAS Life Sciences Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepositsAssetsNoncurrent.

The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SELLAS Life Sciences Group, Inc.'s deposits on licenses.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SELLAS Life Sciences Group, Inc.'s deposits on licenses?
SELLAS Life Sciences Group, Inc. (SLS) reported deposits on licenses of $255K in Q1 2026.
How has SELLAS Life Sciences Group, Inc.'s deposits on licenses changed year-over-year?
SELLAS Life Sciences Group, Inc.'s deposits on licenses decreased by 3.0% year-over-year, from $263K to $255K.
What is the long-term trend for SELLAS Life Sciences Group, Inc.'s deposits on licenses?
Over 5 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s deposits on licenses has grown at a -16.0% compound annual growth rate (CAGR), from $614K to $257K.